Cross icon
Contact us
About us

Company

4Moving Biotech is a clinical-stage biopharmaceutical company founded in 2020.

We are committed to develop first-in-class breakthrough therapies for the millions of patients suffering from osteoarthritis (OA) in the world.

4Moving Biotech’s primary focus is the clinical development of a disease modifying drug for osteoarthritis: 4P004. Our aim is to provide a long-term solution for the high unmet medical need of osteoarthritis.

4Moving Biotech is a subsidiary of 4P-Pharma, an innovation accelerator biotech company.

Leadership

Revital Rattenbach
Revital Rattenbach
Executive Chairwoman
PhD, MBA
Francis Berenbaum
Francis Berenbaum
Chief Medical Officer
MD, PhD

Scientific Advisory Board

Francis Berenbaum
Francis Berenbaum
Philip Conaghan
Philip Conaghan
Felix Eckstein
Felix Eckstein
Ali Guermazi
Ali Guermazi
Yanyan Song
Yanyan Song
Changqing Zhang
Changqing Zhang
Hongyi Zhu
Hongyi Zhu

Would you like to learn more about
our treatment 4P004?